Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos

US10136621B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10136621-B2
Application numberUS-201816011631-A
CountryUS
Kind codeB2
Filing dateJun 18, 2018
Priority dateNov 15, 2013
Publication dateNov 27, 2018
Grant dateNov 27, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for the production of reproductively sterile fish and aquatic animals for aquaculture, the aquarium trade, and control of invasive species are described. The methods include disruption of gonadal development through the administration of compounds that lead to the failure of fertile gonadal development. Compounds may be delivered to the eggs prior to fertilization or water activation or post fertilization and water activation by contacting unfertilized or pre-water-activated fertilized eggs or fertilized eggs in an immersion medium including the compound of interest. Compounds may be conjugated with a molecular transporter compound effective for chorionic transport of the conjugate. The compounds may be antisense Morpholino oligomers that are capable of effectively suppressing the expression of the dead end gene or other essential genes for germ cell development in fish and other egg-producing aquatic animals.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition for treatment of fish eggs to render fish produced therefrom reproductively sterile, said composition comprising an anti-sense Morpholino oligomer conjugated to an octaguanidine dendrimer molecular transporter, wherein said anti-sense Morpholino oligomer suppresses the translation of dead end gene in said fish. 2. The composition of claim 1 , wherein said anti-sense Morpholino oligomer comprises an oligomer selected from the group consisting of oligomers of SEQ ID NOS: 1-4 and variants thereof. 3. The composition of claim 1 , comprising an aqueous medium containing the anti-sense Morpholino oligomer. 4. The composition of claim 1 wherein the fish eggs are unfertilized or pre-water-activated fertilized fish eggs. 5. The composition of claim 4 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 1 to 20 μM. 6. The composition of claim 4 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 3 to 15 μM. 7. The composition of claim 4 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 5 to 10 μM. 8. The composition of claim 1 , wherein the fish eggs are fertilized fish eggs. 9. The composition of claim 8 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 20 to 80 μM. 10. The composition of claim 8 , wherein the concentration of the anti-sense Morpholino oligomer is in a range of from 40 to 60 μM. 11. The composition of claim 1 , wherein the anti-sense Morpholino oligomer is conjugated with 2-[(4-nitrophenyl)oxycarbonylhexamethylenecarbonylpiperazinyl]-4,6-bis {di [di(trifluoro-acetamidohexyl)-aminocarbonyloxyethyl]amino}triazine. 12. The composition of claim 1 , wherein the anti-sense Morpholino oligomer comprises an oligomer selected from the group consisting of oligomers of SEQ ID NOS: 1-4. 13. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises an oligomer of SEQ ID NO: 1. 14. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises an oligomer of SEQ ID NO: 2. 15. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises an oligomer of SEQ ID NO: 3. 16. The composition of claim 12 , wherein the anti-sense Morpholino oligomer comprises oligomer of SEQ ID NO: 4. 17. The composition of claim 1 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 or a variant thereof. 18. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 1 or a variant thereof. 19. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 2 or a variant thereof. 20. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 3 or a variant thereof. 21. The composition of claim 17 , wherein the anti-sense Morpholino oligomer is SEQ ID NO: 4 or a variant thereof. 22. The composition of claim 1 , wherein the anti-sense Morpholino oligomer conjugated to the octaguanidine dendrimer molecular transporter is effective in reproductively sterilizing said fish eggs by the fish eggs being immersed in an immersion medium comprising an effective amount of said anti-sense Morpholino oligomer conjugated to said octaguanidine dendrimer molecular transporter.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10136621B2 cover?
Methods for the production of reproductively sterile fish and aquatic animals for aquaculture, the aquarium trade, and control of invasive species are described. The methods include disruption of gonadal development through the administration of compounds that lead to the failure of fertile gonadal development. Compounds may be delivered to the eggs prior to fertilization or water activation or…
Who is the assignee on this patent?
Univ Maryland
What technology area does this patent fall under?
Primary CPC classification A01K67/0276. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).